-
Microenvironment predicts tumor treatment response
Time of Update: 2021-07-28
In order to fully describe the cancer cells and the surrounding tumor microenvironment, the researchers analyzed the transcriptomes of more than 10,000 cancer patients.
As a result, they found 4 different tumor microenvironment subtypes in 20 cancers .
-
A total of 178,503,429 confirmed cases of new crowns worldwide
Time of Update: 2021-07-28
WHO: The global cumulative number of confirmed cases of new crown reached 178,503,429 WHO: The cumulative number of confirmed cases of COVID-19 worldwide reaches 178,503,429 WHO: Th
-
The promulgation and implementation of the national standard for Chinese medicine formula granules helps the vigorous development of Chinese medicine
Time of Update: 2021-07-28
The promulgation and implementation of the national standards for traditional Chinese medicine formula granules will significantly raise the market threshold and put forward higher requirements for the scale and quality control of enterprises .
-
How to do drug immunogenicity research in the new registration era?
Time of Update: 2021-07-28
Immunogenic drugs may induce harmful immune responses in the body, and can form anti-drug antibodies and neutralizing antibodies.
-
Yabao Pharmaceutical's first Sino-US dual-reported drug, sorafenib tablets, was approved for listing
Time of Update: 2021-07-28
Recently, Yabao Pharmaceutical's 4 generic drug sorafenib tosylate tablets was officially approved for marketing.
The approval and registration of sorafenib tablets is the result of Yabao Pharmaceutical’s continuous high proportion of R&D investment entering the harvest period.
-
Hengrui tops the list!
Time of Update: 2021-07-28
27 billion yuan, an increase of 44% year-on-year, accounting for 55% of total revenue, and its gross profit margin reached 93%, the highest among all businesses .
Source: Hengrui Annual Report to sum up To a certain extent, the revenue of anti-tumor products represents the innovation ability of pharmaceutical companies.
-
Zhang Wenhong: Vaccine is expected to end the new crown epidemic
Time of Update: 2021-07-28
Zhang Wenhong said that if nothing happens, by the end of June this year, China is expected to complete the vaccination target for 40% of the population .
Zhang Wenhong said that at present, scientists around the world generally believe that the possibility of eliminating infectious diseases is very small .
-
Health Commission: 23 new cases were diagnosed on the 21st, including 2 in the local area
Time of Update: 2021-07-28
As of 24:00 on June 21, according to reports from 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps, there are currently 512 confirmed cases (including 17 severe cases), a total of 86,481 cured and discharged cases, and a total of 4,636 deaths.
-
Chinese scientists have discovered a new type of small molecule compound for the treatment of liver cancer
Time of Update: 2021-07-28
My scientist discovered a new type of small molecule compound for the treatment of liver cancer My scientist discovered a new type of small molecule compound for the treatment of li
-
Experts say people with low immunity may need a third dose of vaccine
Time of Update: 2021-07-28
Hong Kong On the same day, Liu Zexing said when attending a radio program that studies have pointed out that the third dose of the new crown vaccine will increase the level of antibodies.
-
The technological innovation of pharmaceutical excipients, the second generation of Suzhou capsule products detonated the market
Time of Update: 2021-07-28
Cheng Zhong said that in response to the transformation of China's pharmaceutical industry, the market's functional requirements for capsule excipients are constantly changing, and the original traditional gelatin capsules can no longer fully meet the needs of more diverse technologies .
-
Double antibody therapy is effective against new coronavirus mutant strains
Time of Update: 2021-07-28
American scientists wrote in the "Nature" magazine published on the 21st that their experiments on mice and hamsters showed that the combination therapy composed of two antibodies "strongly work together" is effective against a variety of (but not all) new coronavirus mutations.
-
Zhong Nanshan: Dare to be a doctor
Time of Update: 2021-07-27
" Facing the flag, Chinese Academy of Engineering academician , director of the National Respiratory Disease Clinical Research Center, First Affiliated Hospital of Guangzhou Medical University, Zhong Nanshan solemn oath collar, two new developments in preparation of party members are Wuhan Take the form of remote video to solemnly swear .
-
The new crown virus has spread in Europe in October 2019?
Time of Update: 2021-07-27
According to reports, scientists from the Milan Cancer Research Center-the National Cancer Institute (Istituto Nazionale Tumori) wrote in a new paper published on the 19th local time that the two laboratories collected a small amount of blood samples before the outbreak of the new crown epidemic.
-
China's generic drug development has changed dramatically in the past 6 years
Time of Update: 2021-07-27
Source: PharmaGo The huge market sales have become a driving force for companies to accelerate the completion of the consistency evaluation of generic drugs .
Source: PharmaGo Correspondingly, the number of products approved to pass the consistency evaluation of generic drugs is also increasing .
-
New pattern!
Time of Update: 2021-07-27
After the implementation of the policies of "separation of licenses and licenses" and "removal of distance between pharmacies", industry competition has intensified, and ordinary people have benefited, while life in small pharmacies has become even more difficult .
-
Health Commission: 48 new confirmed cases on the 22nd, 12 in China
Time of Update: 2021-07-27
As of 24:00 on July 22, according to reports from 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps, there are currently 663 confirmed cases (including 17 severe cases), 87,163 cured and discharged cases, and 4,636 deaths.
-
Anhui starts the collection of cephalexin at the lowest price
Time of Update: 2021-07-27
On July 21, the Anhui Pharmaceutical Joint Procurement Office issued an announcement on the centralized procurement of cephalexin oral normal-release dosage forms .
The announcement clarified that the maximum effective declaration price for this renewal is 0.
Evaluation rules: The lowest price method after evaluation .
-
Zhou Hong, President of Roche Pharmaceuticals China, resigns to Merck's vice president of market access, Bian Xin, to take over
Time of Update: 2021-07-27
At the same time, Merck announced that Zhou Hong will serve as the head of Merck Group Pharmaceutical and Health China and international markets.
-
Incomplete inventory of sky-high drugs
Time of Update: 2021-07-27
The same benefits of drugs mean that the unit price is higher, and the pharmaceutical companies need corresponding regular returns to cover the continuous research and development costs .
Different from the high-priced drugs listed above, the currently approved cell therapy product indications cannot be regarded as rare diseases.
